Clinical Trials in Baltimore

Showing 15621-15640 of 23,476 trials

Improving Provider Counseling Interventions in HIV Practice

NCT00538993

Hypothesis: HIV clinicians trained to deliver brief counseling messages and receiving cues from a brief computer survey on risk behaviors of their patients can counsel have an impact on patient's risk behaviors.

HIV Infections

Johns Hopkins University470 participantsStarted Sep 2003

Baltimore, Maryland, United States

TERMINATEDPhase 2< 1 mile

Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia

NCT00867308

This is a phase II study of lenalidomide in patients with myelodysplastic syndrome (MDS) and with acute myeloid leukemia (AML) with trilineage dysplasia. Patients will receive two cycles of lenalidomide. Patients who respond may given additional cycles of lenalidomide until disease progression.

Myelodysplastic Syndrome

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins32 participantsStarted Jul 2009

Baltimore, Maryland, United States

COMPLETEDPhase 2< 1 mile

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

NCT00326885

The purpose of this study is to determine whether the investigational drug catumaxomab is a safe and effective treatment for recurrent symptomatic malignant ascites.

Malignant Ascites

Neovii Biotech32 participantsStarted Jun 2006

Tucson, Arizona, United States • La Jolla, California, United States • Stanford, California, United States +15 more locations

Improving Provider Counseling Interventions in HIV Practice

Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Find Trials by Condition in Baltimore

Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma

Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective.

PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults

Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients

Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma

A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

Sunitinib Non Small Cell Lung Cancer Patients Over 70

A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection

A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).

A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer

Sym004 in Patients With Advanced Solid Tumors